The National Institutes of Health announced last week that it had begun clinical trials of a Zika vaccine on 80 human subjects, and hoped to begin a second phase in "Zika-endemic countries" in early 2017.
美国国立卫生研究院上周宣布，该院已经开始在80名人类受试者身上开始一种寨卡疫苗的临床试验，并有望于2017年初在“寨卡病毒流行国家”开始二期试验。